Xenglu Met 12.5/1000mg Tablets 28s – for Powerful Type 2 Diabetes Control
Xenglu Met 12.5/1000mg Tablets 28s – for Powerful Type 2 Diabetes Control
Xenglu Met 12.5/1000mg Tablets 28s – for Powerful Type 2 Diabetes Control
Description
Xenglu Met 12.5/1000mg Tablets 28s – Dual-Action SGLT2 + Metformin Therapy with Heart & Kidney Protection
Xenglu Met 12.5/1000mg Tablet combines empagliflozin 12.5mg (SGLT2 inhibitor) with metformin extended-release 1000mg in a single once-daily tablet. This proven combination lowers blood sugar through two complementary pathways: empagliflozin removes excess glucose via urine while metformin reduces liver glucose production and improves insulin sensitivity. The extended-release formula ensures steady 24-hour control, reduces gastrointestinal side effects, and offers added benefits of weight loss, blood pressure reduction, and clinically proven protection against heart failure and kidney disease progression. The 28-tablet pack provides a full month’s supply for convenient daily management.
